BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 12093249)

  • 21. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
    Dunn BK; Ford LG
    Breast J; 2001; 7(3):144-57. PubMed ID: 11469927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M; Moutquin JM; Walton R; Feightner J;
    CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
    Lippman SM; Brown PH
    J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
    Vogel VG
    Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer chemoprevention: current status and future directions.
    Wickerham DL; Tan-Chiu E
    Semin Oncol; 2001 Jun; 28(3):253-9. PubMed ID: 11402435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer chemoprevention.
    Rosenbaum Smith SM; Osborne MP
    Am J Surg; 2000 Oct; 180(4):249-51. PubMed ID: 11113429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
    Ricart JJ
    Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.
    Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ
    Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials.
    Smith RE
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):4-13. PubMed ID: 14613021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians.
    Ball S; Arevalo M; Juarez E; Payne JD; Jones C
    Prev Med; 2019 Dec; 129():105834. PubMed ID: 31494144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of breast cancer.
    O'Regan RM; Jordan VC
    Cancer Treat Res; 2001; 106():137-54. PubMed ID: 11225001
    [No Abstract]   [Full Text] [Related]  

  • 35. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
    Goldhaber SZ
    Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemoprevention of breast cancer: recommendations and rationale.
    Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
    [No Abstract]   [Full Text] [Related]  

  • 37. Breast Cancer Risk-Reducing Medications.
    Graham D; DiNome ML; Ganz PA
    JAMA; 2020 Jul; 324(3):310. PubMed ID: 32692388
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast cancer chemoprevention.
    Mamounas EP
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):727-38. PubMed ID: 11203331
    [No Abstract]   [Full Text] [Related]  

  • 39. [Specific estrogen receptor modulators (SERMs)].
    Trémollières F; Lopes P
    Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.
    Bao T; Prowell T; Stearns V
    Am J Ther; 2006; 13(4):337-48. PubMed ID: 16858170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.